About Personalis (PSNL)
Personalis, Inc. is a cancer genomics company. The Company is focused on the development of therapies by providing molecular data about each patient’s cancer and immune response. The Company has designed NeXT Platform, which provides its biopharmaceu... Read more
- USD1.27
- USD1.28
- USD1.22
- USD2.91
- -21.70%
- 73M
- 252.84k
- 262.60k
- 65M
- 0.89
- -58.80%
Stock News
4 hours ago
Sen. Tom Cotton encourages drivers to drag Gaza cease-fire protestors from blocked roads
CNBC
4 hours ago
With the market oversold, we're buying a geopolitical hedge and an unfairly punished beer stock
CNBC
4 hours ago
Best Stocks To Buy Today? 2 Consumer Stocks In Focus
StockMarket
4 hours ago
US STOCKS-S&P, Nasdaq muted as bond yields rise; UnitedHealth boosts Dow
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
